Actionable Biomarkers for Rheumatoid ArthritisFriday, 30 September 2011 at 09:30 Add to Calendar ▼2011-09-30 09:30:002011-09-30 10:30:00Europe/LondonActionable Biomarkers for Rheumatoid ArthritisMicroarray World Congress in San Francisco, USASan Francisco, USASELECTBIOenquiries@selectbiosciences.com We have developed multiplex proteomic tests to guide therapeutic decision making in rheumatoid arthritis (RA). Through proteomic discovery, we have identified autoantibody and cytokine profiles with predictive utility for two actionable situations in RA. First, to facilitate early diagnosis and initiation of disease-modifying therapies that alter the natural history of RA. Second, to identify patients likely to respond to anti-TNF therapeutics. |